Urban Health Weekly

Tamara Thomas and Dr. Monique Nugent tackle whether the popular saying "If you can't pronounce it, don't eat it," still holds value for mindful eating.

Cory Rice, DO, a practitioner specializing in Functional Medicine and anti-aging medicine, and Chief Clinical Advisor for Biote Medical, talks about the next steps for patients who have discontinued GLP-1s but still require assistance with reversing their health conditions.

Dr. Alessandra Maleddu, a Medical Oncologist and Sarcoma Specialist at the University of Colorado, talks about desmoid tumors. She highlights methods for enhancing patient diagnosis through imaging techniques and the importance of referring patients to a sarcoma specialist.

After years of misdiagnoses and, later, infertility, April Christina was diagnosed with stage four endometriosis. She talks about the challenges of getting properly diagnosed as a Black woman, the emotional toll of infertility, and her experience with IVF. April Christina also emphasizes the importance of support systems, faith, and advocacy, as well as the resources available through Fertility Out Loud.

Gregg Sylvester, MD, Chief Health Officer of CSL Seqirus, details why this year’s flu season is particularly severe.

Dr. Andrew Hertler, Senior Advisor / Chief Medical Officer – emeritus for Evolent, explains ODAC’s September 2024 vote to support the FDA’s decision to restrict the use of PD-1 inhibitor drugs such as Opdivo, Keytruda, and Tevimbra for PD-L1-negative stomach cancer and esophageal cancer, and his support of using biomarkers to predict outcomes.

Dr. Bruce Dorr, MD, FPMRS, FACOG, discusses menopausal women who possess gene mutations, such as BRCA1/2 or PTEN, and what they need to know about Hormone Replacement Therapy.

Tamara Thomas and Dr. Monique Nugent debate whether the FDA should actively inform the public that its FDA GRAS loophole allows companies to test and report on their food products.